IGF-1 DES

Overview

IGF-1 DES (Insulin-like Growth Factor 1 DES(1-3)) is a truncated variant of the naturally occurring IGF-1 peptide. It is studied in laboratory settings for its enhanced potency and shorter half-life, which allow researchers to investigate its effects on localized cell growth, muscle regeneration, and tissue repair in preclinical models such as laboratory rodents.

Benefits

Preclinical studies suggest that IGF-1 DES may promote increased muscle cell proliferation, enhance satellite cell activation, and support tissue repair more effectively than standard IGF-1 due to its greater bioavailability in targeted tissues. Researchers use IGF-1 DES to study muscle hypertrophy, recovery, and regenerative processes in various laboratory models.
Source: Florini JR, et al. IGF-1 and muscle growth: new insights into mechanisms of action. American Journal of Physiology, 1996.

Possible Side Effects

In laboratory research, test subjects administered IGF-1 DES may exhibit mild side effects such as localized injection site irritation, temporary swelling, or slight fluctuations in blood glucose levels. Effects vary based on dosage, study duration, and species used.
Source: Florini JR, et al., Am J Physiol, 1996.

Dosage & Administration

IGF-1 DES is typically administered via subcutaneous or intramuscular injection following approved laboratory protocols. Typical research dosages range from 20 mcg to 100 mcg per injection, often administered once or twice daily for short research cycles, depending on the study goals and the species involved.
For laboratory research use only. Not for human consumption.

Summary

IGF-1 DES is a potent truncated variant of IGF-1 developed exclusively for laboratory research focused on muscle cell proliferation, tissue repair, and regeneration in preclinical models. Research suggests it may deliver localized anabolic effects with mild side effects such as injection site irritation or slight blood sugar fluctuations occasionally observed in test subjects. IGF-1 DES is administered via subcutaneous or intramuscular injection, with dosage and frequency tailored to the specific study design and species.
Strictly for research purposes only. Not for human use.